BMS 6078 (Metaglip 5 mg / 500 mg)
Generic Name: glipizide/metformin
This pill with imprint "BMS 6078" is Pink, Elliptical / Oval and has been identified as Metaglip 5 mg / 500 mg. It is manufactured by Bristol-Myers Squibb.
Metaglip is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metaglip 5 mg / 500 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- glipizide/metformin
- Imprint:
- BMS 6078
- Strength:
- 5 mg / 500 mg
- Color:
- Pink
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00087-6078
More about Metaglip (glipizide / metformin)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: antidiabetic combinations
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
